Literature DB >> 17205316

5-HT2 receptor mechanisms of the dorsal periaqueductal gray in the conditioned and unconditioned fear in rats.

Luciana Chrystine Oliveira1, Ana Carolina Broiz, Carlos Eduardo de Macedo, J Landeira-Fernandez, Marcus Lira Brandão.   

Abstract

RATIONALE: It is well known that 5-HT(2) mechanisms modulate the defensive behavior produced by the stimulation of the dorsal periaqueductal gray (dPAG). However, in spite of the notion that past stressful experiences play a role in certain types of anxiety, only studies with the stimulation of the dPAG of rats without previous aversive experience have been conducted so far.
OBJECTIVES: We investigated the mediation of 5-HT(2) receptors of the dPAG in rats previously submitted to contextual fear conditioning (CFC). Defensive behaviors induced by the activation of the dPAG were assessed by measuring the lowest intensity of electric current applied to this structure (threshold) able to produce freezing and escape responses during the testing sessions of CFC in which animals were placed in a context previously paired to footshocks. The 5-HT(2) function of the dPAG in this condition was evaluated by local injections of alpha-methyl-5-HT (20 nmol/0.2 mul) and ketanserin (5 and 10 nmol/0.2 mul), selective agonist and antagonist of 5-HT(2) receptors, respectively.
RESULTS: In accordance with previous studies, alpha-methyl-5-HT increased the aversive thresholds (antiaversive effects) in naive rats, and injection of ketanserin into the dPAG did not produce significant effects. On the other hand, ketanserin decreased in a dose-dependent manner the freezing threshold (proaversive effect) determined by the dPAG electrical stimulation, whereas alpha-methyl-5-HT continued to show antiaversive effects in animals under CFC.
CONCLUSIONS: The present results suggest that past stressful experience can produce changes in the synaptic function of 5-HT(2) receptors within the dPAG with important impact on the expression of defensive behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205316     DOI: 10.1007/s00213-006-0653-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Lesion of the ventral periaqueductal gray reduces conditioned fear but does not change freezing induced by stimulation of the dorsal periaqueductal gray.

Authors:  D M Vianna; F G Graeff; J Landeira-Fernandez; M L Brandão
Journal:  Learn Mem       Date:  2001 May-Jun       Impact factor: 2.460

Review 2.  Modeling panic attacks.

Authors:  L C Schenberg; A S Bittencourt; E C Sudré; L C Vargas
Journal:  Neurosci Biobehav Rev       Date:  2001-12       Impact factor: 8.989

Review 3.  Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle.

Authors:  D L Walker; J V Cassella; Y Lee; T C De Lima; M Davis
Journal:  Neurosci Biobehav Rev       Date:  1997-11       Impact factor: 8.989

4.  Neuroanatomical correlates of a lactate-induced anxiety attack.

Authors:  E M Reiman; M E Raichle; E Robins; M A Mintun; M J Fusselman; P T Fox; J L Price; K A Hackman
Journal:  Arch Gen Psychiatry       Date:  1989-06

5.  Electrophysiological evidence for excitatory 5-HT2 and depressant 5-HT1A receptors on neurones of the rat midbrain tectum.

Authors:  M L Brandão; J A Lopez-Garcia; F G Graeff; M H Roberts
Journal:  Brain Res       Date:  1991-08-16       Impact factor: 3.252

Review 6.  5-HT2 receptor subtypes: a family re-united?

Authors:  G Baxter; G Kennett; F Blaney; T Blackburn
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

7.  Role of resocialization and of 5-HT1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test.

Authors:  S Maisonnette; S Morato; M L Brandão
Journal:  Physiol Behav       Date:  1993-10

8.  Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses.

Authors:  B M De Oca; J P DeCola; S Maren; M S Fanselow
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

9.  Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle.

Authors:  Julia Maria Santos; Ana Carolina Gárgaro; Amanda Ribeiro Oliveira; Sueli Masson; Marcus Lira Brandão
Journal:  Eur Neuropsychopharmacol       Date:  2005-03       Impact factor: 4.600

Review 10.  Serotonin, the periaqueductal gray and panic.

Authors:  Frederico G Graeff
Journal:  Neurosci Biobehav Rev       Date:  2004-05       Impact factor: 8.989

View more
  5 in total

Review 1.  Defensive and Emotional Behavior Modulation by Serotonin in the Periaqueductal Gray.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Kenji Valencia-Flores; Hugo Sánchez-Castillo
Journal:  Cell Mol Neurobiol       Date:  2022-07-28       Impact factor: 4.231

2.  Activation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeat.

Authors:  Matthew A Cooper; Kathleen E McIntyre; Kim L Huhman
Journal:  Psychoneuroendocrinology       Date:  2008-08-09       Impact factor: 4.905

3.  The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats.

Authors:  Paul V Strong; Benjamin N Greenwood; Monika Fleshner
Journal:  Psychopharmacology (Berl)       Date:  2008-11-27       Impact factor: 4.530

4.  Involvement of midbrain tectum neurokinin-mediated mechanisms in fear and anxiety.

Authors:  J C Brenes; A C Broiz; G S Bassi; R K W Schwarting; M L Brandão
Journal:  Braz J Med Biol Res       Date:  2012-03-08       Impact factor: 2.590

5.  Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats.

Authors:  Laura A León; Vitor Castro-Gomes; Santiago Zárate-Guerrero; Karen Corredor; Antonio P Mello Cruz; Marcus L Brandão; Fernando P Cardenas; J Landeira-Fernandez
Journal:  Front Behav Neurosci       Date:  2017-07-07       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.